Arcutis Biotherapeutics, Inc. (ARQT)
27.53
-0.85
(-3.00%)
USD |
NASDAQ |
Nov 12, 16:00
27.04
-0.49
(-1.78%)
After-Hours: 06:58
Arcutis Biotherapeutics Price to Book Value : 14.22 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 14.22 |
| November 11, 2026 | 14.66 |
| November 10, 2026 | 14.15 |
| November 09, 2026 | 13.53 |
| November 06, 2026 | 13.20 |
| November 05, 2026 | 13.95 |
| November 04, 2026 | 17.59 |
| November 03, 2026 | 16.53 |
| November 02, 2026 | 16.15 |
| October 30, 2026 | 16.57 |
| October 29, 2026 | 16.51 |
| October 28, 2026 | 16.25 |
| October 27, 2026 | 16.36 |
| October 26, 2026 | 16.43 |
| October 23, 2026 | 16.12 |
| October 22, 2026 | 16.63 |
| October 21, 2026 | 16.46 |
| October 20, 2026 | 16.95 |
| October 19, 2026 | 16.47 |
| October 16, 2026 | 14.89 |
| October 15, 2026 | 15.03 |
| October 14, 2026 | 13.64 |
| October 13, 2026 | 13.48 |
| October 12, 2026 | 13.54 |
| October 09, 2026 | 13.73 |
| Date | Value |
|---|---|
| October 08, 2026 | 12.65 |
| October 07, 2026 | 12.48 |
| October 06, 2026 | 12.36 |
| October 05, 2026 | 12.99 |
| October 02, 2026 | 13.00 |
| October 01, 2026 | 13.06 |
| September 30, 2026 | 13.65 |
| September 29, 2026 | 15.23 |
| September 28, 2026 | 15.56 |
| September 25, 2026 | 15.33 |
| September 24, 2026 | 14.96 |
| September 23, 2026 | 15.02 |
| September 22, 2026 | 15.82 |
| September 21, 2026 | 14.78 |
| September 18, 2026 | 14.45 |
| September 17, 2026 | 15.07 |
| September 16, 2026 | 14.88 |
| September 15, 2026 | 13.39 |
| September 14, 2026 | 13.82 |
| September 11, 2026 | 13.60 |
| September 10, 2026 | 13.31 |
| September 09, 2026 | 13.57 |
| September 08, 2026 | 13.89 |
| September 04, 2026 | 13.61 |
| September 03, 2026 | 13.47 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.259 |
| ADMA Biologics, Inc. | 6.727 |
| Alnylam Pharmaceuticals, Inc. | 5.819 |
| Anika Therapeutics, Inc. | 1.344 |
| Savara, Inc. | 8.995 |
Price to Book Value Related Metrics
| PE Ratio | 127.69 |
| PS Ratio | 7.276 |
| Price to Free Cash Flow | 61.99 |
| Price | 27.53 |
| Earnings Yield | 0.78% |
| Market Cap | 3.469B |
| Operating PE Ratio | 105.25 |
| Normalized PE Ratio | 127.39 |